Literature DB >> 11226581

Localization of a new neutralizing epitope on the mumps virus hemagglutinin-neuraminidase protein.

M G Cusi1, S Fischer, R Sedlmeier, M Valassina, P E Valensin, M Donati, W J Neubert.   

Abstract

Four protein fragments which span the entire hemagglutinin-neuraminidase protein (HN) of mumps virus were expressed in HeLa cells and cell extracts were tested for their capability to induce neutralizing antibodies in mice. Fragment HN3 (aa 213-372) was able to induce the production of hemagglutination-inhibiting and neutralizing antibodies. When a subfragment of HN3, the synthetic peptide NSTLGVKSAREF (aa 329-340 of HN) was used for immunization, hemagglutination-inhibiting and neutralizing antibodies against mumps wild type virus but not against the Urabe Am9 vaccine virus were raised. The peptide could, therefore, contain a new epitope, which may be critical for protective host humoral immune response.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11226581     DOI: 10.1016/s0168-1702(00)00254-9

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  17 in total

1.  Recent mumps outbreaks in vaccinated populations: no evidence of immune escape.

Authors:  Steven A Rubin; Malen A Link; Christian J Sauder; Cheryl Zhang; Laurie Ngo; Bert K Rima; W Paul Duprex
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

2.  Inorganic nanovectors for nucleic acid delivery.

Authors:  Sandhya Pranatharthiharan; Mitesh D Patel; Anisha A D'Souza; Padma V Devarajan
Journal:  Drug Deliv Transl Res       Date:  2013-10       Impact factor: 4.617

3.  Characterization of mumps viruses circulating in Mongolia: identification of a novel cluster of genotype H.

Authors:  Minoru Kidokoro; Rentsengiin Tuul; Katsuhiro Komase; Pagbajab Nymadawa
Journal:  J Clin Microbiol       Date:  2011-03-16       Impact factor: 5.948

4.  Genomic characterization of mumps viruses from a large-scale mumps outbreak in Arkansas, 2016.

Authors:  Duah Alkam; Piroon Jenjaroenpun; Thidathip Wongsurawat; Zulema Udaondo; Preecha Patumcharoenpol; Michael Robeson; Dirk Haselow; William Mason; Intawat Nookaew; David Ussery; Se-Ran Jun
Journal:  Infect Genet Evol       Date:  2019-07-15       Impact factor: 3.342

Review 5.  Exploring the Mumps Virus Glycoproteins: A Review.

Authors:  Jasmine Rae Frost; Saba Shaikh; Alberto Severini
Journal:  Viruses       Date:  2022-06-18       Impact factor: 5.818

6.  Immunogenicity of Mumps Virus Genotype G Vaccine Candidates in Jeryl Lynn-Immunized Mice.

Authors:  Kelsey Briggs; Cara Kirby; Ashley C Beavis; James Zengel; Preetish Patil; Christian Sauder; Biao He
Journal:  J Virol       Date:  2022-04-07       Impact factor: 6.549

7.  Trisaccharide containing α2,3-linked sialic acid is a receptor for mumps virus.

Authors:  Marie Kubota; Kaoru Takeuchi; Shumpei Watanabe; Shinji Ohno; Rei Matsuoka; Daisuke Kohda; Shin-Ichi Nakakita; Hiroaki Hiramatsu; Yasuo Suzuki; Tetsuo Nakayama; Tohru Terada; Kentaro Shimizu; Nobutaka Shimizu; Mitsunori Shiroishi; Yusuke Yanagi; Takao Hashiguchi
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-26       Impact factor: 11.205

8.  Genetic variation in the HN and SH genes of mumps viruses: a comparison of strains from mumps cases with and without neurological symptoms.

Authors:  Aili Cui; David W G Brown; Wenbo Xu; Li Jin
Journal:  PLoS One       Date:  2013-04-24       Impact factor: 3.240

9.  Antigenic differences between vaccine and circulating wild-type mumps viruses decreases neutralization capacity of vaccine-induced antibodies.

Authors:  M Šantak; M Lang-Balija; J Ivancic-Jelecki; T Košutić-Gulija; S Ljubin-Sternak; D Forcic
Journal:  Epidemiol Infect       Date:  2012-09-07       Impact factor: 4.434

10.  Genotype replacement of the human parainfluenza virus type 2 in Croatia between 2011 and 2017 - the role of neutralising antibodies.

Authors:  M Šantak; M Lang Balija; G Mlinarić Galinović; S Ljubin Sternak; T Vilibić-Čavlek; I Tabain
Journal:  Epidemiol Infect       Date:  2018-06-18       Impact factor: 4.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.